Literature DB >> 28895126

Construction of an Exome-Wide Risk Score for Schizophrenia Based on a Weighted Burden Test.

David Curtis1,2.   

Abstract

Polygenic risk scores obtained as a weighted sum of associated variants can be used to explore association in additional data sets and to assign risk scores to individuals. The methods used to derive polygenic risk scores from common SNPs are not suitable for variants detected in whole exome sequencing studies. Rare variants, which may have major effects, are seen too infrequently to judge whether they are associated and may not be shared between training and test subjects. A method is proposed whereby variants are weighted according to their frequency, their annotations and the genes they affect. A weighted sum across all variants provides an individual risk score. Scores constructed in this way are used in a weighted burden test and are shown to be significantly different between schizophrenia cases and controls using a five-way cross-validation procedure. This approach represents a first attempt to summarise exome sequence variation into a summary risk score, which could be combined with risk scores from common variants and from environmental factors. It is hoped that the method could be developed further.
© 2017 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Association; exome; schizophrenia

Mesh:

Year:  2017        PMID: 28895126     DOI: 10.1111/ahg.12212

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  5 in total

1.  Association study of schizophrenia with variants in miR-137 binding sites.

Authors:  David Curtis; Warren Emmett
Journal:  Schizophr Res       Date:  2017-11-20       Impact factor: 4.939

2.  A weighted burden test using logistic regression for integrated analysis of sequence variants, copy number variants and polygenic risk score.

Authors:  David Curtis
Journal:  Eur J Hum Genet       Date:  2018-09-26       Impact factor: 4.246

3.  Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology.

Authors:  David Curtis; Leda Coelewij; Shou-Hwa Liu; Jack Humphrey; Richard Mott
Journal:  Behav Genet       Date:  2018-03-21       Impact factor: 2.805

4.  A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.

Authors:  Chiara Fabbri; Siegfried Kasper; Alexander Kautzky; Joseph Zohar; Daniel Souery; Stuart Montgomery; Diego Albani; Gianluigi Forloni; Panagiotis Ferentinos; Dan Rujescu; Julien Mendlewicz; Rudolf Uher; Cathryn M Lewis; Alessandro Serretti
Journal:  Transl Psychiatry       Date:  2020-02-03       Impact factor: 6.222

Review 5.  Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment.

Authors:  Chiara Fabbri; Stuart Montgomery; Cathryn M Lewis; Alessandro Serretti
Journal:  Int Clin Psychopharmacol       Date:  2020-09       Impact factor: 2.023

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.